Clinical manifestations of ocular toxoplasmosis in Yogyakarta, Indonesia: A clinical review of 173 cases

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 34, Issue 2, 2003, Pages 291-297

  Suhardjo, ^a   Utomo, Purjanto Tepo ^a   Agni, Angela Nurini ^a  

^a GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; DEXAMETHASONE; FANSIDAR; FOLINIC ACID; PYRIMETHAMINE; SPIRAMYCIN; SULFADOXINE; SULFAMETHOXAZOLE; TRIMETHOPRIM; TRISULFA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BLINDNESS; CHILD; CHORIORETINITIS; CLINICAL FEATURE; CONGENITAL CATARACT; DEMOGRAPHY; EYE INFECTION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INDONESIA; INFANT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MUSCLE CRAMP; NAUSEA; NYSTAGMUS; ONSET AGE; OPTIC DISK ANOMALY; PAIN; RETINA MACULA LUTEA; REVIEW; RISK FACTOR; SCAR FORMATION; STEROID THERAPY; STRABISMUS; STUDENT; THROMBOCYTOPENIA; TOXOPLASMA; TOXOPLASMOSIS; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT; VOMITING;

EID: 0141628929     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Akstein RB, Wilson LA, Teutsch SM. Acquired toxoplasmosis. Ophthalmology 1982; 89: 1299-302.
2. Araujo F, Slifer T, Kim S. Chronic infection with Toxoplasma gondii does not prevent acute disease or colonization of the brain with tissue cysts following reinfection with different strains of the parasite. J Parasitol 1997; 83: 521-2.
3. Bosch-Driessen EH, Rothova A. Recurrent ocular disease in post-natally acquired toxoplasmosis. Am J Ophthalmol 1999; 128: 421-5.
4. Bosch-Driessen LH, Karimi S, Stilma JS, Rothova A. Retinal detachment in ocular toxoplasmosis. Ophthalmology 2000; 107: 36-40.
5. Couvreur J, Thulliez P. Acquired toxoplasmosis of ocular or neurologic site: 49 cases. Presse Med 1996; 25: 438-42 (in French).
6. Da Mata AP, Orefice F. Toxoplasmosis. In: Foster CS, Vitale AT, eds. Diagnosis and treatment of uveitis. Philadelphia: Saunders, 2002: 385-90.
7. Fernandez LC, Orefice F. Aspectos clinicos e epidemiologicos due uveitis em service de referencia em Belo Horizonte 1970-1993, parte L. Rev Bras Oftal 1996; 55: 579-92.
8. Frenkel JK. Immunity in toxoplasmosis. Bull Pan Am Health Organ 1985;19:354-67.
9. Gandahusada S. Toksoplasmosis: epidemiologi, patogenesis, dan diagnosis. Dalam Gandahusada S dan Sutanto I, eds. Kumpulan Makalah Simposium Toksoplasmosis, FK UI, Jakarta, Aug 11. 1990.
10. Gandahusada S. Toxoplasma gondii. In: Gandahusada S, Illahude HD, Wita P, eds. Parasitologi Kedokteran, edisi ketiga. BP FKUI. 2000: 153-60.
11. Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol 1992; 114: 136-44.
12. Henin D, Duyckaerts C, Chaunu MP, et al. Neuropathological study of 31 cases of acquired immunodeficiency syndrome. Rev Neurol (Paris) 1987; 143: 631-42 (in French).
13. Holland GN, O'Connor GR, Belfort R, Remington JS. Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular infection and immunity. St Louis: Mosby, 1996: 1083-223.
14. Holland GN. Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol 1999; 128: 502-5.
15. Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 2002; 134: 102-14.
16. Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG. Ocular manifestations of acquired immunodeficiency syndrome. Ophthalmology 1989; 96: 1092-9.
17. Lafaul BA, Meire FM, Leys AM, Dralands G, De-Laey JJ. Vasoproliferative retinal tumors associated with peripheral chorioretinal scars in presumed congenital toxoplasmosis. Graefes Arch Clin Exp Ophthalmol 1999; 237: 1033-8.
18. Mets HB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1996; 122: 309-24.
19. Nunuk MU, Suhardjo. Congenital toxoplasmic retinochoroiditis causing strabismus. J Med Sci 1988; 20: 45-50.
20. Ongkosuwito JV, Bosch-Driessen EH, Kijlstra A, Rothova A. Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. Am J Ophthalmol 1999; 128: 407-12.
21. Orefice F, Bonfioli AA. Toxoplasmose. In: Orefice F, ed. Uveite clinica e cirurgica (in prelo). Rio de Janeiro, Brazil: Editora Cultura Medica, 1999.
22. Silviera C, Belfort R Jr, Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 2002; 134: 41-6.
23. Smith RE, Ganley JP. Ophthalmic survey of a community. 1. Abnormalities of the ocular fundus. Am J Ophthalmol 1972; 74: 1126-30.
24. th ed. East Norwalk, Conn: Appleton and Lange, 1992: 158-9.
25. Whittle RM, Wallace GR, Whiston RA, Dumonde DC, Stanford MR. Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol 1998; 82: 1017-21.
26. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980; 66: 767-74.